Fig. 4From: A novel and more efficient biosynthesis approach for human insulin production in Escherichia coli (E. coli)A graph illustrating the cell viability of HepG2 cells, under hyperglycaemic conditions for standard human insulin and crude biosynthesised human insulin at low (50 ng/mL), medium (100 ng/mL) and high (150 ng/mL) MTT concentrations (p-value < 0.0001)Back to article page